The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: a quasi experimental study

Table 3 Factor affecting EQ-5D utility score and EQ-VAS score difference

Variable	Utility Score Difference	P	EQ-VAS Score Difference	P
Gender
Male, n = 3	0.011 ± 0.018	0.083	11.67 ± 7.64	0.242
Female, n = 15	0.001 ± 0.109	0.083	16.67 ± 5.77	0.242
Age
< 38 y.o, n = 9	0.089 ± 0.114	0.656	4.44 ± 9.17	0.119
≥ 38 y.o, n = 9	0.122 ± 0.210	0.656	10 ± 7.50	0.119
Education status
Low, n = 2	0.254 ± 0.530	1.000	15 ± 7.10	0.166
High, n = 16	0.062 ± 0.042	1.000	6.25 ± 8.47	0.166
Marital Status
Married, n = 15	0.052 ± 0.034	0.339	13.33 ± 11.55	0.460
Not Married, n = 3	0.185 ± 0.160	0.339	5 ± 13.23	0.460
Occupation
Employed, n = 5	0.027 ± 0.045	0.091	9 ± 7.42	0.443
Unemployed, n = 13	0.494 ± 0.460	0.091	4 ± 8.9	0.443
Other treatment
With treatment, n = 8	0.192 ± 0.208	0.089	5 ± 9.64	0.249
No treatment, n = 10	0.051 ± 0.050	0.089	8.13 ± 8.43	0.249
Comorbid disease
With comorbid disease, n = 2	0.099 ± 0.140	0.944	2.5 ± 3.54	0.511
Without comorbid disease, n = 16	0.106 ± 0.171	0.944	10 ± 14.14	0.511

Description: Mann Whitney test analysis results showed p value> 0.05 in all sub groups. This means that there is no statistically significant difference between the factors affecting HRQoL to the difference of EQ-5D utility score and EQ-VAS score, * p < 0.05

ISSN: 1477-7525